СПИСОК ОСНОВНОЙ ЛИТЕРАТУРЫ

1. WHO. The HΓV∕AIDS pandemic: 1994 overview. — WHO, Geneva,

1994. - 16 p.

2. Centers for Disease Control. Cases of selected notifiable diseases, ending February 10, 1996.

3. Mann J., Tarantola D., Netter T (editors). AIDS in the World ∕∕ Harvard University Press, Cambridge. — 1992. — 1038 p.

4. Centers for Disease Control. Pneumocystis Pneumonia — Los Angeles 11 Morbidity and Mortality Weekly Report. — 1981. — Vol. 30. — P.305-307.

5. Centers for Disease Control. Persistent, generalized Iymphadenopathy among homosexual males ∕∕ Ibid. — 1982. — Vol. 31. — P.249—252.

6. Centers for Disease Control. Update on Kaposi’s sarcoma and opportunistic infections in previously healthy persons. — United States ∕∕ Ibid. —

1982. - Vol. 31. - P.294-301.

7. Centers for Disease Control. Pneumocystis carinii pneumonia among persons with hemophilia ∕∕ Ibid. — 1982. — Vol. 31. — P.365—367.

8. Centers for Disease Control. Update on AIDS. — United States ∕∕ Ibid. —

1982. - Vol. 31. - P.507-514.

9. Centers for Disease Control. Possible transfusion-associated AIDS. — California ∕∕ Ibid. - 1982. - Vol. 31. - P.652-654.

10. Centers for Disease Control. Immunodeficiency among female sexual partners of males tfith AIDS. — New-York ∕∕ 1983. — Vol. 31. — P. 697-698.

11. Centers for Disease Control. Prevention of AIDS: report of interagency recommendations ∕∕ Ibid. — 1983. — Vol. 32. — P. 101—104.

12. Centers for Disease Control. The safety of hepatitis B virus ∕∕ Ibid. —

1983. - Vol. 32. - P. 134-136.

13. Centers for Disease Control. Update: AIDS — Europe ∕∕ Ibid. — 1984. — Vol. 33. - P.607-609.

14. Centers for Disease Control.

15. Scott G.B.. Buck B.E., Leterman J. G. et al. AIDS in infants ∕∕ New Eng. J. of Med. - 1984. - Vol. 310. - P.76-79.

Barre-Sinoussi F., Chermatn J.C., Rey F. et al. Isolation of T-Iymphot- ropic retrovirus from patient at risk for AIDS ∕∕ Science. — 1983. — Vol. 220. - P.868—871.

WHO. WHO guidelines for standard HΓV isolation procedures. — WHO, Geneva, 1994. — 53 p.

Myers G., Korber B., Wdin-Hobson S., Jeang KT, Henderson L.E., Pavlakis G.N. Human retroviruses and AIDS. — Los Alamos National Laboratory. — Los Alamos. — 1994.

Connor S. Research shows how HΓV exhausts the body ∕∕ Brit. Med. J. —

1995. - Vol. 310. - P.6973-7145.

Hu D.J., Dondero TJ., Ryefild M.A., George RJ. Scholheman G., Jaffe H W. et al. The emerging genetic diversity of HIV ∕∕ JAMA. — 1996. — № L-P.210-216.

Csillag C. HIV-I SubtypeC in Brazil ∕∕ Lancet. — 1994. — Vol. 344, № 8933. - P.1354.

Reznick L., Veren K, Salahuddin S.Z. et al. Stability and inactivation of HTLV-III∕LAV // Journal of American Medical A⅛ociation. — 1986. — Vol. 255.- P. 1887-1891.

Spinivasan A., Jork D., McComick et al. Genetic organization of HTLV- III∕LAV isolated from a serum sample collected in 1976 in Central Africa ∕∕ II international conference on AIDS. — Paris, 1986. — P.17. Centers for Disease Control. Semen banking, organ and tissue transplan­tation and HIV-antibody testing ∕∕ Morbidity and Mortality Weekly Report. - 1988. - Vol. 37. - P.57-58.

Charmann J.-C., Becker J.L., Hazan U. et al. HIV related sequence in insects from Central Africa ∕∕ III international conference on AIDS. — Washington, 1987.— P. 16.

Jupp P.G., Lyons S.F. Experimental assessment of begbags and mosqui­toes as vectors of HIV ∕∕ Ibid. — P.16.

Levy J.A. HIV: detection and pathogenesis ∕∕ in AIDS pathogenesis and treatment.

Mayer KH., Stooldard A.M., Me. Casker J. et al. HTLV-III in high risk, antibodynegative homosexual men ∕∕ Ann. Intern. Med. — 1986. — Vol. 104. - P. 194-196.

Salahuddin S.Z., Groopman J.E., Markham P.D. et al. HTLV-III in symptom free seronegative persons ∕∕ Lancet. — 1984. — Vol. 2. — P.1418.

Institute of Medicine. Confronting AIDS. Update 1988. — Washington: National Academy Press., 1988. — 240 p.

Rutherford G. W. Long-term survival in HIV-infection ∕∕ Brit. Med. J. — 1994. - VoL309, № 6950. - P.283-284.

Ward J. W., Holmberg S.D., Allen J.R et al. Transmission of HΓV by blood transfusions screened as negative for HIV antibody ∕∕ New Engl. J. Med. - 1988. - Vol. 318. - P.473-478.

33. Cooper D.A., Gold J., Maclean P. et al. Acute retroviral infection ∕∕ Lancet. — 1985. — Vol. 1 — P. 537 — 540.

34. Кравченко A.B., Юрин O. Γ, Eypaeupea Е.В. и др. Ранние клинические проявления ВИЧ-инфекции UМед. помощь. — 1993. — № 5. — С.26-28.

35. В.И. Покровский. ВИЧ-инфекция или СПИД? // Тер.арх. — 1989. — № 11.-С.3-6.

36. Krovka J.F., Moody D.J., Stites D.P. Immunological effects of HΓV-in- fection ∕∕ in AIDS pathogenesis and treatment. — Ed. Levy J.A. Marcel Dekker inc. — New York and Basel, 1989. — P.257—305.

37. Fauci A.S. Impact of biomedical research on the AIDS epidemic ∕∕ in Science challenging AIDS. — Karger. — Basel. — 1992. — P. 1—14.

38. Pantaleo G., Graziozi C., Demarest J.F. et all. HIV infection is active and progressive in lymphoid tissue during the clinically Iatemt stage of disease ∕∕ Nature. — 1993. — Vol.362, № 6418. — P.357—358.

39. Institute of Medicine. Confronting AIDS. Update 1988. — Washington, National Academy Press. — 1988. — 240 p.

40. IKffO-EC Collaborating Centre for the epidemiological monitoring of AIDS. HΓV∕AIDS Surveillance in Europe.

41. WHO. Provisional WHO clinical case definition for AIDS ∕∕ Weekly epidemiological record. — 1986. — № 10. — P.71.

42. Imagawa D. T et al. HIV-1 infection in homosexual man who remains seronegative for prolonged periods ∕∕ New. Eng. J. Med. — 1989. — Vol. 320, № 22. - P. 1458.

43. Haseltine W.A. Silent HIV infections (editorial) ∕∕ New. Eng. J. Med. — 1989. - Vol. 320, № 22. - P.1457.

44. Currel J. Silent HΓV-infection appears rare ∕∕ AIDS Clin. Care. — 1991.-Vol. 3, № 12.-P.96.

45. Эткин А.Ф., Покровский B.B., Янкина 3.K.Анализ специфичности серодиагностики СПИД // Журн. микробиол. — 1986. — № 9. — С.73-76.

46. Global Programme on AIDS WHO. Operational characteristics of com­mercially available assays to detect antibodies to HIV-I and/or HIV-2 in human sera. Report 6 ∕∕ WHO, Geneva. — March, 1993. — 68 p.

47. Суворова 3.K., Eypaeupea EJ}., Деулина M.O., Покровский B.B.Сероло­гическая диагностика инфекций, вызываемых ВИЧ, иммунофермент- ными методами // Мед. помощь. — 1993. — № 5. — С.22—24.

48. CZflzic S.J, Saag M.S., Dekker W.D. et al. High titers of cytopathic virus in plasma of patients with symptomatic HΓV-infection and AIDS ∕∕ New. Eng. J. Med. - 1991. - Vol. 324, № 14. - P.954-959.

49. Clement M. When should the PCR be used in diagnosing HIV-infection ∕∕ AIDS Clinical Care. - 1990. - Vol.2. - P.34.

50. Mortimer P.M. The fallibility of HIV Western blot ∕∕ Lancet. — 1991. — Vol. 337. - P.703 -710.

Sato Р.А., Maskill W.J., Tomashiro H., Heymann D.L. Strategies for laboratory HIV testing: an examination of alternative approaches not requiring Western blot ∕∕ Bulletin of WHO. — 1994. — Vol. 72. — P. 129-134.

WHO. Recommendation for the selection and use of HIV antibody tests ∕∕ WHO Weekly epidemiological record. — 1992. — № 20. — P. 145-149.

Winn M. The Greem Reaper: Australia’s first mass media AIDS education campaign ∕∕ in AIDS prevention through health promotion.

Покровский B.B., Мазус А.И., Акимов А.И. Анонимное обследование населения на антитела к вирусу, вызывающему СПИД // Журн. микробиол. — 1989. — № 3. — С.53—57.

WHO. Statement from the consultation on testing and counselling for HIV infection. — WHO, Geneva, 1993. — P. 12.

Dondero TJ., Pappaioanou M., Curran J. W. Monitoring the level and trends of HΓV infection ∕∕ Pdblic Helth Rep. — 1988. — Vol. 103. — P.213-220.

Heyward W.L., Curran J. W. Epidemiology of AIDS in the US ∕∕ Scientific American. — 1988. — Vol. 259, № 4. — P.72—81.

World Health Organization. AIDS policies and programmes in the European region. — WHO, Copenhagen, 1989. — 117 p.

Pankova G., Galina M., Morgunova N, Pokrovsky V. Provider and partner refferal in partner notification and risk of HIV transmission ∕∕ X International Conference on AIDS. — Yokohama, 1994. — Vol.2. — P.271.

Покровский B.B., Янкина 3.K., Топоровский Л.М. и др. Первичный серологический скрининг инфекции, вызываемой вирусом LAV/ HTLVIΠ∕HΓV в Москве // Журн. микробиол. - 1987. - № 7. - С.21-23.

Покровский В.В., Виноград Д.Л., Деулина М.О. и др. Серологичес­кий скрининг инфекции вирусом иммунодефицита в 1987 г. // Там же. - 1988. - № 12. - С.56-59.

Покровский В.В., Ерамова И.Ю. Проникновение ВИЧ в популяцию московских гомосексуалистов и распространение в ней // Там же. — 1990,- №4.-С. 18-22.

Pape J. W., Liantand B., Thomas F. et al. The AIDS in Haiti ∕∕ Ann. Intem.Med. - 1985. - Vol. 103. - P.674-678.

Bartolomew C., Mahabir B., Clegnom F. et al. HTLV-I and HTLV-III infections in Trinidad and Tobago ∕∕ IV international conference on AIDS. — Stockliohn, 1987. — P.127.

Chout R., Cales-Quist D., Helenon R et al. Seroepidemiological study of LAV∕HTLV-ΠI infection in Martinique ∕∕ Ibid. — P.127.

Vigneron-Meleder H, Pradinand R. Joly F et al. AIDS in French Gaiana ∕∕ Ibid.

67. Villarejos VM., Vasona K., Comero R. Epidemiology of AIDS in Costa Rica ЦIbid. - P. 127.

68. Merino F., Volsky D.J., Rodriguez J. et al. Anti-HTLV∕LAV antibodies among native population in Venezuela ∕∕ Ibid. — P. 128.

69. Centers for Disease Control. Update: AIDS — Europe ∕∕ Morbidity and Mortality Weekly Report. — 1984. — Vol. 33. — P.607—609.

70. Bigbjerg LC. AIDS in Danish surgeon (Zaire, 1976) ∕∕ Lancet. — 1983. — Vol. 1. - P.925.

71. Vandepitte J., Verwillghen R., Zachee P. AIDS and cryptococcosis (Zaire, 1977) ЦIbid. - P.925 - 926.

72. World Health Organization. Guidelines on AIDS in Europe. — WHO, Copenhagen, 1985. — 57 p.

73. Saxinger W.C., Levine P.H., Dean A.G. Evidence for exposure to HTLV- III in Uganda before 1973 ∕∕ Science. — 1985. — Vol. 227. — P.1036— 1038.

74. Clumeck N., Sonnet J., Tadman H. AIDS in African patients ∕∕ N. Eng. J. Med. - 1984. - Vol. 310. - P.492-497.

75. Van de Perre P., Clumeck N., Garael M. et al. Female prostitutes: a risk group for infection with HTLV-III∕LAV ЦLancet. — 1985. — Vol. 2. — P.62-65.

76. Georges A.J., Gonsales J.B., McCormiok A.B. Antibodies to LAV/ HTLV-III in Central African Republic ∕∕ III international conference on AIDS. - Paris, 1986. - P.130.

77. Giraldo E.B., Giraldo G., Gharbi R.M. ASM infection in Tunisia ∕∕ Ibid. — P.128.

78. Desmyter J., Goubou R., Charmarets M., Montagnier L. Anti- LAV∕HTLV-III in Kinshasa Mothers ∕∕ Ibid. — P.104.

79. Titty F, Acety A, Verani P., Rossi G.B. Seroepidemiological screening in Somalia ∕∕ Ibid. — P.130.

80. Rouzioux C., Saeger G., Brun-Vesinet F. Absence of AB to LAV in Pygmics ∕∕ Ibid. — P.130.

81. Lyons S.F._r Schoub B.D., McGillivray, Sher R. Seroepidemiology of HTLV-III in Southern Africa ∕∕ South African Med. J. — 1987. — Vol. 67. - P.961-962.

82. Kumagai F., Morio S., Jano H. Epidemiological aspects of AIDS in Japan U Ibid. — P.154.

83. Leon E.K., Li P.C.K., Chang W.K. et al. Epidemiology of LAV∕HTLV- III antibodies in Hong Kong ∕∕ Ibid. — P.127.

84. Weniger B. G., Wdsi C., Traisura H. Prevalence of HTLV∕LAV antibodies in Thailand ∕∕ Ibid. — P. 127.

85. Yi Z. Seroepidemiological studies on HΓV-antibody in Chine ∕∕ Second workshop on epidemiology and ∞ntrol of AIDS. — Токіо, 1990. — P.15.

86. Whyte B.M., Gold J., Dobson A.J., Cooper DA. Epidemiology of AIDS in Australia ∕∕ Med. J. Austr. — 1987. — Vol. 146. — P.65—69.

World Health Organization. Guidelines on AIDS in Europe. — WHO, Copenhagen, 1985. — 57 p.

Покровский B.B., Поль P.T.СПИД: можно ли остановить эпиде­мию ЦM.: Изд-во Секретариата СЭВ, 1989. — 43 с.

Centers for Disease Control. Sexually transmitted disease statistic calen­dar year 1988 ∕∕ CEXD, Atlanta, 1988. — 58 p.

Zagury D., Lurbama Z. AIDS control in Africa ∕∕ in AIDS. 2nd ed. — Philadelphia, 1988. - P.431-445.

Quinn T.C., Mann J.M., Carran J.W., Piot P. AIDS in Africa: An Epidemiologic Paradigm ∕∕ Science. — 1986. — Vol.234. — P.955—963.

Jaffe H.W., Hardy A.M., Morgan W.M., Darrow W. W. The AIDS in gay men U Annal of Internal Medicine. — 1985. — Vol. 103. — P.662—664.

Mann J. Global AIDS into the 1990s ∕∕ Geneva, 1989. — 8 p.

Покровский B.B., Суворова 3.K. Мангушев Т.Н. Инфекция, вызываемая ВИЧ-2, в СССР // Жури, микробиол. - 1988. - № 10. - С.20 -22.

Jaffe H. W., Hardy А.М., Morgan W.M., Darrow W. W. The AIDS in gay men U Ann. Intern. Med. — 1985. — Vol.103. — P.662—664.

Detels R., Fahey J.L.. Schwarts R., Green R.S. Relation between sexual practices and T-cell subsets in Iiomosexually active men ∕∕ Lancet. — 1983.-Vol. 1. - P.609-611.

Marmor M. Risk factors ∕∕ AIDS. Basic guide for clinicians. — Copen­hagen. — Munksguard, 1984. — 1—312 p.

Benzle U., Guggenmoos-Holzrnann I., Zwingebetger K. Lymphadenopathy and antibodies to HTLV-III in homosexual men ∕∕ Klin. Wch. — 1985. - Vol. 63. - P.597-602.

Blattner W.A., Biggar R.J., Weiss S.H. et al. Epidemiology of HTLV-III and the risk of the AIDS ∕∕ Annal of Internal Medicine. — 1985. — Vol. 103. - P.665-670.

Friedland M.D., Harris C., Butkas-Small C. et al. Intravenous drug abusers and AIDS ∕∕ Archive of Internal Medicine. — 1985. — Vol. 145. — P. 145-149.

Lang R.W., Snyder FR., Lozovsky D. et al. Geographic distribution of HIV markers in parenteral drug abusers ∕∕ Amer. J. Pub. Hlth. — 1988. - Vol. 78. - P.443-446.

Савченко И.Г., Покровский B.B.Факторы риска ВИЧ-инфекции в России среди употребляющих наркотики внутривенно // Мед. по­мощь. — 1993. — № 5. — С. 19—23.

Wykoff R. Children and transfusion related AIDS ∕∕ Journal of State Medical Society. — 1985. — Vol. 137. — P.65—69.

Stem-Geen J.K., Holman R.C., Jason J.M. et al. Hemophilia-associated AIDS in the US U Amer. J. Publ. Hlth. - 1988. - Vol. 78. - P.439- 442.

Evatt B.L., Gomperts E.D., McDongal J.S., Ramsey R.B. Coincidental appearance of LAV∕HTLV-III antibodies in hemophiliacs and the onset

of the AIDS epidemic ∕∕ New Eng. J. Med. — 1985. — Vol. 312. — P.483-486.

106. Curran J.W., Lawrence D.N., Jaffe H. et al. AIDS associated with transfusions ∕∕ New Eng. J. Med. — 1987. — Vol. 310. — P.69—72.

107. Rouzioux C., Chamaret S., Montagnier L. et al. Absence of antibodies to AIDS virus in haemophiliacs treated with heat-treated factor VIII ∕∕ Lancet. - 1985. - Vol. 1. - P.271-272.

108. Rouzioux C., Brun-Vezinet F., Conrouce A.M. et al. Immunoglobulin G. antibodies to LAV in differently treated French and Belgian hemophiliacs ∕∕ Annal of Internal Medicine. — 1985. — Vol. 102. — P.476-479.

109. Rogers M.F, Thomas P., Stradier T et al. National surveillance for AIDS in children ∕∕ II international conference on AIDS. — Paris, 1986. — P.99.

110. Thomas P., Desjarlais D., Odonell R., Deren S. The epidemiology of maternally transmitted AIDS in children in New York ∕∕ Ibid. — P. 123.

111. Chiolo F., Ricchi E., Costigltola B. et al. Vertical transmission of LAV/ HTLV-III ∕∕ II international conference on AIDS. — Paris, 1986. — P. 127.

112. Ziegler JB., Cooper D.A., Johnson R.O. et al. Postnatal transmission of AIDS-associated retrovirus from a mother to an infant ∕∕ Lancet. — 1985. - Vol. 1. - P.896-897.

113. Покровский B.B., Сервецкий К.Л. Передача ВИЧ при грудном вскар­мливании и гетеросексуальных контактах // Журн. микробиол. — 1988. - № 12. - С.59-62.

114. Melbye M., Indersler J., Biggar R.J. et al. Anal intercourse as a possible factor in heterosexual transmission of HTLV-III in spouses of hemo­philiacs ∕∕ New Eng. J. Med. — 1985. — Vol. 312. — P.857—859.

115. Groopman J.E., Sargadharan M.G., Salahuddin S.Z. et al. Apparent transmission of HTLV-III to a heterosexual woman with AIDS ∕∕ Annal of Internal Medicine. — 1985. — Vol. 102. — P.63—66.

116. Redfield R.R., Markham PD., Salahuddin S.Z. et al. Heterosexually acquired HTLV-III disease ∕∕ Journal of American Medical Associa­tion. - 1985. - Vol. 254»— P.2094-2096.

117. Heterosexually acquired HTLV-III disease ∕∕ Redfield RR, Markham P.D., Salahuddin S.Z. et al ∕∕ Journal of American Medical Associa­tion. - 1985. - Vol. 254. - P.2094-2096.

118. Redfield R.R., Wright D.C., Markham P.D. et al. Frequent bidirectional heterosexual transmission of HTLV-IΠ∕LAV between spouses ∕∕ II international conference on AIDS. — Paris, 1986. — 125 p.

119. Ftschl M.A., Dickinson G.M., Scott G.B. et al. Heterosexual and house­hold transmission of the HTLV-III ∕∕ Ibid. — P.107.

120. Redfield R.R., Wright D.C., Markham PD. et al. Frequent bidirectional heterosexual transmission of HTLV-III∕LAV between spouses ∕∕ Ibid. — P.125.

121. KogZ M.W., Witt D.J., Craven D.E. et al. Isolation of LAV∕HTLV-III from female genital secretion ∕∕ Ibid. — P. 14.

122. Mann J., Quinn T.C., Piot P. et al. Condom use and HIV infection among prostitute in Zaire ∕∕ New Eng. J. Med. — 1987. — Vol. 316. — P.345-349.

123. Fransen C., Jertbom M., Bibetfield M. Four generations of heterosexual transmission of LAV∕HTLV-III in a small Swedish town ∕∕ III interna­tional conference on AIDS. — Paris, 1985. — 123 p.

124. Centers for Disease Control. Antibody to HΓV in female prostitute ∕∕ Morbidity and Mortality Weekly Reports. — 1987. — VoL 36. — P. 157— 161.

125. Кузнецова И.И., Покровский В.В. Роль женщины в распространении инфекции, вызываемой ВИЧ // Мед. помощь. — 1993. — № 5. — С. 15-19.

126. Jason J.M., McDougal J.S., Dixon G. et al. HTLV-I∏∕LAV antibody and immune status of household contacts and sexual partners of persons with hemophilia ∕∕ Ibid. - 1986. - Vol. 255. - P.212-215.

127. Scott GB., Fischl M.A., Klimas N. et al. Mothers of infants with the AIDS ЦJ. Amer. Med. Assoc. - 1985. - Vol. 253. - P.363-366.

128. RosenbergMJ., Weiner J.M. Prostitutes and AIDS, a health department priority? ∕∕ Amer. J. Pub. Hlth. — 1988. — Vol. 78. — P.418—423.

129. Spitzer P.G. Weiner N.J. Transmission of HIV from a woman to a man by oral sex U Eng. J. Med. - 1989. - Vol. 320, № 4. - P. 251

130. Salahuddin S.Z., Markham P.D., Redfleld R.R. et al. HTLV-III in symptom-free seronegative persons ∕∕ Lancet. — 1984. — Vol. 2. — P.1418-1421.

131. Marmor M., Weiss L.R., Lyden M. et al. Possible female-to-female transmission of HIV ∕∕ Ann. Intern. Med. — 1986. — Vol. 105. — P.969-970.

132. Glasel M. High risk sexual practices in the transmission of AIDS ∕∕ AIDS. - Philadelphia, 1988. - 355-364 p.

133. Rogers M.F., Jcffe H. W. Reduction the risk of maternal-infant transmis­sion of HΓV a door is opened ∕∕ New Eng. J. Med. — 1994. — Vol. 331, № 18. - P. 1222-1223.

134. Centers for Disease Control. HIV-infection transmitted from an organ donor screened for HΓV-antibody. — North Carolina ∕∕ Ibid. — 1987. — Vol. 36. - P.306-308.

135. Clark J.A. HIV transmission and skin draft ∕∕ Lancet. — 1987. — Vol. 1. - P.983.

136. Stewart G.L., Tyler J.P.R., Cunningham A.L. et al. Transmission of HTLV-IΠ∕LAV by artificial insemination by donor ∕∕ Lancet. — 1985. — Vol. 2. - P.581-584.

137. Maccray E. Prospective evaluation on health care workers with parenteral or mucous-membrane exposure to blood or other body fluid from patient

with AIDS U II international conference on AIDS. — Paris, 1986. — P. 107.

138. Kunls TL., Vilker S., Parris NB., Garakian A. A prospective cohort study of the occupational risk of AIDS in health care personall ∕∕ Ibid. — P. 117.

139. Henderson D.K., Saah A.J., Zak B.J. et al. Risk for nosocomial infection with LAV∕HTLV-III ∕∕ Ibid. - P. 124.

140. Oksenhendler E., Harzik M., Le Roux K. et al. HIV-infection with seroconversion after a superficial needle stick injury to a finger ∕∕ New Eng. J. Med. - 1986. - Vol. 315. - P.582.

141. Neisson-Vemant C., Arfis T., Mathez D. et al. Needlestick HIV serocon­version in a nurse ∕∕ Lancet. — 1986. — Vol. 2. — P.814.

142. Centers for Disease Control. Update: AIDS and HIV-infection among health-care workers ∕∕ Morbidity and Mortality Weekly Reports. — 1988. - Vol. 37. - P.229-234.

143. Gerberding J.L. Managment of Occupatinal exposhure to blood-born viruses U New Engl. J. Med. — 1995. — Vol. 332, № 7. — P.444— 449.

144. Centers for Disease Control. Possible transmission of HΓV to a patient during an invasive dental procedure ∕∕ Morbidity and Mortality Weekly Report. - 1990. - Vol. 39. - P. 489-493.

145. Покровский В.И., Покровский B.B.СПИД // М: Медицина, 1988. — 45 с.

146. Bobkov A., Cheungsong-Popov R., Garaev М.et al. Identification f an env G subtype and geterogenity of HΓV-strains in Russian Federation and Belarus ∕∕ AIDS. - 1994. - Vol. 8. - P. 1649-1655.

147. Покровский B.B., Ерамова И.Ю., Липетиков B.Bи др. Внутрибо­льничная вспышка ВИЧ-инфекции в Элисте // Журн. микробиол. — 1990. - №4. - С. 17-23.

148. Chang К., Lowe D., Rubin G. Patient-to-patient transmission of HIV in private surgical consulting rooms ∕∕ Lancet. — 1993. — Vol. 342, № 8886— 8887. - P. 1548-1549.

149. Apertrei R.C., Buszduran I., Mitroi I. et al. Nosocomial HΓV transmission and primary prevention in Romania ∕∕ Lancet. — 1994. — Vol. 344, № 8928. - P. 1029.

150. Lifson A.R. Do alternative modes for transmission of HΓV exist? ∕∕ J. Anier. Med. Assoc. - 1988. - Vol. 259. - P. 1353-1356.

151. Peterman TA., Stonebumer R.L., Allen J.R. Risk of HTLV-ΠI∕LAV transmission to household contacts of persons with transfusion-associ­ated HTLV-III∕LAV infection ∕∕ II international conference on AIDS. — Paris, 1986. - P. 107.

152. Saltzrnan B.R., Friedland G.H., Rogers M.F. et al. Lack of household transmission of HTLV-IΠ∕LAV infection ∕∕ Ibid. — P. 107.

153. Mann J.M.,Quinn TC., Francis H. et al. Prevalence of HTLV-III∕LAV in household contacts of adults with AIDS ∕∕ J. Amer. Med. Assoc. — 1987. - Vol. 257. - P.640-644.

154. Centers for Disease Control. Apparent transmission of HTLV-III∕LAV from a child to a mother providing health care ∕∕ Morbidity and MortaUty Weekly Reports. — 1986. — Vol. 35. — P.76—79.

155. Wahn V., Kramer H.H., Voit K et al. Horizontal transmission of HIV-infection between two siblings ∕∕ Lancet. — 1986. — Vol. 2. — P.694— 696.

156. Salahuddin S.Z, Markham P.D., Redfleld R.R. et al.HTLV-III in symp­tom-free seronegative persons ∕∕ Lancet. — 1984. — Vol. 2. — P. 1418— 1421.

157. Покровский B.B., Ерамова И.Ю., Кузнецова И.И. и др. Передача ВИЧ от ребенка матери во время кормления грудью // Журн. микробиол. — 1990. — № 3. — С.23—26.

158. Фукс Э. История нравов. Галантный век ∕∕ M.: Республика, 1994. — 479 с.

159. Torre D. et al. Transmission of HΓV-1 infection via sport injury ∕∕ Lancet. - 1990. - Vol. 335, № 8697. - P.1166.

160. Tompson C.A. A sUppery defence against HΓV ∕∕ Lancet. — 1993. — Vol. 342, № 8886—8887. - P. 1500.

161. Neal K. Origins of HΓV ∕∕ Lancet. — 1992. — Vol. 339, № 8810. — P.58.

162. Покровский B.B., Юрин O.Γ., Кравченко A.В., ∏omeκaeβ H.C.Первый случай ВИЧ-инфекции у гражданина СССР // Журн. микробиол. — 1992,—№ 11-12. - С. 19-22.

163. Покровский В.В., Янкина З.К. Эпидемиологическое расследование первого случая СПИД, выявленного у гражданина СССР // Журн.микробиол. — 1987. — № 12. — С.8—11.

164. Громашевский Л.В. Общая эпидемиология ∕∕ M.: Медицина. — 1965. - 290 с.

165. Galh R. С.The AIDS virus ∕∕ Scientific American. — 1987. — Vol. 256. — P.46-56.

166. Покровский B.B._rЯнкина 3.K._rПокровский В.И. и др. СПИД и генерализованная лимфаденопатия у лиц, серопозитивных к виру­су HIV // Тер. арх. - 1987. - № 7. - С.35-37.

167. Зимин Ю.И., ∏omeκaeβ Н.С., Шигунина Е.А., Парфанович М.И. СПИД (клиническое наблюдение) // Тер. арх. — 1987. — № 7. — С.42-45.

168. Lachman J.L. Heterosexual AIDS as a Global problem ∕∕ Natal witness printing and publishing Company. — Pietermartizburg, South Africa. — 1995. - 716 p.

169. Imam Z. India's AIDS control programme is unsatisfactory ∕∕ Brit. Med. J. - 1994. - Vol. 308, № 6933. - P.877.

170. Clements A. Thailand stifles AIDS campaign ∕∕ Brit. Med. J. — 1992. — Vol. 304, № 6837. - P.1264.

171. WHO Weekly Epidemiological record ∕∕ WHO. — 1995. — № 70. — P.335 -357.

172. UNIAIDS. HΓV∕AIDS: figure and trends //UNIAIDS, Geneva. - 1996. - P.4.

173. UNIAIDS. HIV∕AIDS data ∕∕ UNIAIDS Geneva. - 1996. - P. 17.

174. Landesman S.H., Ginsburg H.M., Weiss S.H. The AIDS epidemic ∕∕ New Engl. J. Med. - 1985. - Vol. 312. - P.521-525.

175. Wryte B.M., Evans D.B., Schreurs E.J., Cooper D.A. The costs of hospital-based medical care for patients with the AIDS ∕∕ Med. J. Aust. - 1987. - Vol. 147. - P.269-272.

176. Bamett T., Blaikie P. AIDS in Africa: Its present and future impact. — London: Belhaven Press, 1992. — p.89.

177. W∏0. Effective approaches for the prevention of HIV∕AIDS in women ∕∕ WHO, Geneva. — 1995. — 60 p.

178. WHO. Background paper preparatory meeting for a consultation on long­term travel restrictions and HΓV∕AIDS. — WHO, Geneva, 1995. — 26 p.

179. WHO. WHO guidelines on HΓV infection and AIDS in prisons. — WHO, Geneva, 1995. — 10 p.

180. International Federation of Red Cross and Red Crescend Societies, WHO. Guidelines for blood donor councelling on HΓV. — Geneva, 1994. - 28 p.

181. Joseph J.G., Montgomery S.B., Emmons C.A et al. Magnitude and determinants of behavioral risk reduction: longitudinal analysis of a cohort of gay men ∕∕ Psychology and Health. — 1995. — Vol. 1. — P.73-96.

182. Division on AIDS. NIH. Zidovudin for the prevention of HΓV transmis­sion from mother to infant ∕∕ Morbidity and Mortality Weekly Report. — 1994. - Vol.343, № 8909. - P.285 -288.

183. Petricciani J.C., Gust LD. Hoppe P.A. Krijnen H. W. AIDS. The safety of bl∞d and blood products»// WHO, Chichester, 1987. — 374 p.

184. Newell M.-L. Caesarian section and the risk of vertical transmission of HIV-I H Lancet. - 1994. - Vol. 343, № 8911. - P.1464-1467.

185. Detels R., English P., Visscler B.R. Seroconversion, sexual activity, and condom use among 2915 HIV seronegative men followed for up to two years ЦJ. AIDS. - 1989. - Vol. 2 (1). - P.77-83.

186. Richter J.,Donovan B., Gerofi B. How often do condoms break or slip off in use? H Intern. J. STD and AIDS. — 1993. — Vol. 4, № 2. — P.90— 94.

187. Novelh A C., Petyerson H.B., Arrowsmith-Lowe J. T et al. From the Sergeon General. — US Public Health Service ∕∕ J. Amer. Med. Assoc. — 1993. - Vol. 269, № 22. - P.2840.

188. Boer K, de Vries J., de Beauford I.D.ВИЧ и репродуктивный выбор ∕∕ Русский медицинский журнал. — 1995. — № 5. — С.297— 302.

189. Anonimous. HIV Seroconvertion after occupational explosure despite early profilactic Zidovudin treatment ∕∕ Lancet. — 1993. — Vol. 341. — P. 1077-1078.

190. Australian Government. AIDS: a time to care — a time to act ∕∕ Canberra. — 1988. — 295 p.

191. Покровский B.B., Акимов А. И. Оценка эффективности информации населения о СПИД методом телефонного анкетирования // Журн.микробиол. — 1988. — № 10. — С. 20— 22.

192. Pollak M., Dur W., Vmcineau М.et al. Evaluating AIDS prevention for men having sex with men: The West european experience ∕∕ Social and preventive medicine. — 1994. — Vol. 39, Suppl. 1. — P.47—61 .

193. Reztf G > Rota M.C., Burning E, et al. Assessing HIV prevention among injecting drug users in European Community countries ∕∕ Soc. prevent, med. — 1994. — Vol. 39, Suppl. 1. — P.61—7.

194. WHO. Report on meeting on international regulatory harmonization for HΓV∕AIDS drugs and vaccines. — WHO, Geneva, 1993. — 17 p.

195. UNESCO, WH O/GPA. The costs of HIV∕AIDS prevention strategies in developing contries. — WHO, Geneva, 1993. — 61 p.

196. WH0∕GPA. ModelUng the costs of prevention: a resource requirement model for developing countries. — WHO, Geneva, 1995. — 37 p.